These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 6051694)

  • 1. [Velocity of the selective accumulation of Mercurascan 203 in injured muscle and in the ischemic myocardium].
    Málek P; Vavrejn B; Ratuský J; Kronrád L; Kolc J
    Experientia; 1967 Aug; 23(8):649-51. PubMed ID: 6051694
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
    Málek P; Vavrejn B; Kolc J; Ratuský J
    Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complex effect of mercurascan on ischaemia-induced myocardial injury].
    Málek P; Kolc J; Vrána M; Kucerová V; Mrhová O; Vránová Z
    Cas Lek Cesk; 1975 Jun; 114(25):753-7. PubMed ID: 1157063
    [No Abstract]   [Full Text] [Related]  

  • 4. Uptake of 203Hg-hydroxy-mercury-fluorescein in myocardial infarcts.
    Ramanathan P; Ganatra RD; Daulatram K; Sen PK; Blau M
    J Nucl Med; 1971 Sep; 12(9):641-3. PubMed ID: 5571890
    [No Abstract]   [Full Text] [Related]  

  • 5. Mercurascan test in ischaemia of the heart muscle caused by permanent ligature of the coronary artery.
    Málek P; Kolc J; Vavrejn B; Ratuský J; Kronrád L
    Rev Czech Med; 1971; 17(1):11-5. PubMed ID: 5576153
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of Mercurascan-203Hg by rats and dogs.
    Dreyfuss J; Ross JJ; Shaw JM
    J Nucl Biol Med; 1973; 17(2):43-50. PubMed ID: 4754433
    [No Abstract]   [Full Text] [Related]  

  • 7. [The effect of mercurascan on some of the metabolic parameters of myocardial ischaemia in the early phases after heart transplantation in the dog (author's transl)].
    Brodan V; Táborský J; Hejnal J; Málek P; Andĕl M
    Cas Lek Cesk; 1979 Apr; 118(14):438-40. PubMed ID: 378375
    [No Abstract]   [Full Text] [Related]  

  • 8. [Scintigraphic visualization of cardiac infarct. Experimental studies of the distribution of chloromedrin-Hg203 in the tissues].
    Pucci C; Ferri O; Augusti A
    Minerva Chir; 1971 Sep; 26(18):1011-23. PubMed ID: 5129423
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of mercury derivatives of fluorescein on the fibrillation threshold in experimental myocardial infarction.
    Málek P; Kolc J; Vrána M; Blazek Z
    Experientia; 1971 Mar; 27(3):273. PubMed ID: 5546638
    [No Abstract]   [Full Text] [Related]  

  • 10. Ischaemia detecting radioactive substances for scanning cardiac and skeletal muscle.
    Malek P; Ratusky J; Vavrejn B; Kronrad L; Kolc J
    Nature; 1967 Jun; 214(5093):1130-1. PubMed ID: 6053080
    [No Abstract]   [Full Text] [Related]  

  • 11. [Scintiscanning in myocardial infarct using "Mercuroscan"].
    Ballaira L
    Riv Crit Clin Med; 1968; 68():Suppl 6:947+. PubMed ID: 5747766
    [No Abstract]   [Full Text] [Related]  

  • 12. Changes of ion activities in heart and skeletal muscle during exercise and ischemia [proceedings].
    Hirche H; Franz C; Schumacher E
    Arzneimittelforschung; 1978; 28(5):866-7. PubMed ID: 581967
    [No Abstract]   [Full Text] [Related]  

  • 13. [Further advances in the topical diagnosis of ischemic myocardial lesions in vivo].
    Málek P; Vavrejn B; Ratuský J; Kolc J; Kronrád L
    Cas Lek Cesk; 1966 Nov; 105(47):1273-8. PubMed ID: 5979879
    [No Abstract]   [Full Text] [Related]  

  • 14. [Mercuroscan--a new diagnostic and antiarrhythmic drug in ischemic heart disease].
    Málek P; Vavrejn B; Kolc J; Ratuský J; Kronrád L; Vrána M; Prerovský I
    Rozhl Chir; 1971 Apr; 50(4):164-71. PubMed ID: 5579819
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on isoprenaline-induced myocardial lesions. 1. Quantitative evaluation by mercurascan uptake.
    Faltová E; Mráz M; Kronrád L; Protivová L; Sedivý J
    Basic Res Cardiol; 1977; 72(5):454-63. PubMed ID: 588200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of Mercurascan after coronary artery ligation in the dog.
    Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
    Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of a new diagnostic and antiarrhythmic agent, mercurascan, in experimental myocardial infarct].
    Malek P; Vavreĭn B; Kolts I; Vrana M; Ratuskiĭ I
    Eksp Khir Anesteziol; 1975; (6):3-11. PubMed ID: 1234540
    [No Abstract]   [Full Text] [Related]  

  • 18. Myocardial uptake studies with 129Cs and the scintillation camera.
    Yano Y; Van Dyke D; Budinger TF; Anger HO; Chu P
    J Nucl Med; 1970 Nov; 11(11):663-8. PubMed ID: 5476928
    [No Abstract]   [Full Text] [Related]  

  • 19. Postmortem diagnosis of ventricular fibrillation by K and Na distribution in the myocardium and skeletal muscle in out-of-hospital sudden death from acute ischemic heart disease.
    Raiskina ME; Opalyeva-Stegantseva VA; Ratovskaya VI; Ostapova VN; Veber OP
    Am Heart J; 1977 Aug; 94(2):154-62. PubMed ID: 878983
    [No Abstract]   [Full Text] [Related]  

  • 20. Cardiac energetics.
    Gibbs CL
    Physiol Rev; 1978 Jan; 58(1):174-254. PubMed ID: 146205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.